Status:

COMPLETED

To Evaluate Safety & Reactogenicity of GSK Bio's Human Rotavirus (HRV) Vaccine in Filipino Infants at Least 6 Weeks of Age at First Vaccination

Lead Sponsor:

GlaxoSmithKline

Conditions:

Infections, Rotavirus

Rotavirus Vaccines

Eligibility:

All Genders

6-24 years

Brief Summary

GSK has submitted a registration file for its live attenuated oral human rotavirus (HRV) vaccine in several countries. In view of its registration in the Philippines, the present study will collect da...

Detailed Description

The protocol was amended to reflect a change in the prescribing information. The age of the infants was changed from 6 - 14 weeks to at least 6 weeks at the time of the first vaccination. This protoco...

Eligibility Criteria

Inclusion

  • Subjects who the investigator believes that their parents/guardians can and will comply with the requirements of the protocol (e.g. completion of the diary cards, return for follow-up visits) should be enrolled in the study.
  • A Filipino male or female aged at least 6 weeks at the time of the first vaccination.
  • Written informed consent obtained from the parent or guardian of the subject.

Exclusion

  • History of allergic disease or reactions likely to be exacerbated by any component of the vaccine.
  • Any history of chronic gastrointestinal disease including any uncorrected congenital malformation of the GI tract.
  • Any contraindications as stated in the Prescribing Information.

Key Trial Info

Start Date :

November 16 2006

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

July 17 2010

Estimated Enrollment :

1439 Patients enrolled

Trial Details

Trial ID

NCT00353366

Start Date

November 16 2006

End Date

July 17 2010

Last Update

March 16 2021

Active Locations (18)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 5 (18 locations)

1

GSK Investigational Site

Alabang, Muntinlupa City, Philippines, 1780

2

GSK Investigational Site

Binangonan, Rizal, Philippines

3

GSK Investigational Site

Cainta, Rizal, Philippines

4

GSK Investigational Site

City of Muntinlupa, Philippines, 1780